Molecule intelOpportunity: Lower0

1 Microgram Of Saccharide For Serotype 1

2 brands · 2 companies · product forms

Opportunity snapshot

Launch attractiveness
27
Market saturation
5
Price room
0
Regulatory risk
0
2
brands
2
companies
Rs 7,363.4
median price
2
price points
1x
price spread
40
confidence %

Excluded from opportunity ranking — likely noisy resolution.

Who competes here

Top companies by brand count — concentrated market · leader share 50%

Price room

Across observed sources and strengths
CheapestRs 7,363.4
MedianRs 7,363.4
Most expensiveRs 7,363.4
Spread1×
Sources: DRAP-official

Only 2 trusted price points; variation not scored (low data).

Why this score

Launch attractiveness

40% supply-gap(40) + 25% price-variation(0) + 20% low-competition(95) + 15% supply-disruption(0), damped by confidence(40). Higher = more attractive, less crowded opportunity.

Market saturation

2 canonical companies and 2 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

Only 2 trusted price points; variation not scored (low data).

Regulatory risk

No DRAP alerts on this molecule's brands.

Confidence

Reduced by: few brands, sparse price data, no ATC code.

Packaged brief for this lower opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.